The National Institute of Allergy and Infectious Diseases is offering grants for milestone-driven projects aiming to develop vaccines targeting Mycobacterium tuberculosis infection and tuberculosis disease. The focus is on establishing proof-of-concept and preclinical development of lead candidate vaccines. Applications for this grant opportunity should support research in vaccine development against TB. Closing date for submissions is on March 2, 2017, at 12:00 AM EST.
Opportunity ID: 289357
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-16-079 |
Funding Opportunity Title: | Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Tuberculosis Disease (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 05, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Mar 02, 2017 |
Current Closing Date for Applications: | Mar 02, 2017 |
Archive Date: | Apr 02, 2017 |
Estimated Total Program Funding: | $6,200,000 |
Award Ceiling: | $1,050,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Small businesses Independent school districts Native American tribal governments (Federally recognized) City or township governments County governments Private institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on establishing proof-of-concept for and/or preclinical development of lead candidate vaccines targeting infection with Mycobacterium tuberculosis (Mtb) and/or tuberculosis disease (TB). |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-079.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00228435 | Feb 02, 2017 | Mar 02, 2017 | View |
Package 1
Mandatory forms
289357 RR_SF424_2_0-2.0.pdf
289357 PHS398_CoverPageSupplement_3_0-3.0.pdf
289357 RR_OtherProjectInfo_1_3-1.3.pdf
289357 PerformanceSite_2_0-2.0.pdf
289357 RR_KeyPersonExpanded_2_0-2.0.pdf
289357 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
289357 RR_Budget_1_3-1.3.pdf
289357 RR_SubawardBudget30_1_3-1.3.pdf
289357 PHS398_ModularBudget_1_2-1.2.pdf
289357 PHS_Inclusion_Enrollment_Report-1.0.pdf
289357 PHS_AssignmentRequestForm-1.0.pdf